Literature DB >> 18428077

Methadone- and heroin-related deaths in Florida.

Noni A Graham1, Lisa J Merlo, Bruce A Goldberger, Mark S Gold.   

Abstract

Methadone is a potent synthetic opioid used for treatment of opioid dependence and chronic pain. Florida Department of Law Enforcement data were analyzed to examine trends in deaths related to or caused by methadone and/or heroin between 2001-2006. Results demonstrated that mortalities associated with methadone use increased steadily as mortalities associated with heroin decreased steadily. Though useful in the treatment of opioid dependence and chronic pain, methadone possesses high abuse potential and documented mortality risks. Treatment with methadone, for both pain and opioid dependence, should be preceded by an abuse liability evaluation. Attempts to minimize diversion should be implemented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428077     DOI: 10.1080/00952990802010892

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  15 in total

Review 1.  Update in addiction medicine for the primary care clinician.

Authors:  Adam J Gordon; David A Fiellin; Peter D Friedmann; Marc N Gourevitch; Kevin L Kraemer; Julia H Arnsten; Richard Saitz
Journal:  J Gen Intern Med       Date:  2008-10-02       Impact factor: 5.128

2.  Using multiple cause-of-death data to improve surveillance of drug-related mortality.

Authors:  David L Nordstrom; Mieko L Yokoi-Shelton; Amy Zosel
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct

3.  Why aren't physicians prescribing more buprenorphine?

Authors:  Andrew S Huhn; Kelly E Dunn
Journal:  J Subst Abuse Treat       Date:  2017-04-12

Review 4.  Indicators of buprenorphine and methadone use and abuse: what do we know?

Authors:  Jane Carlisle Maxwell; Elinore F McCance-Katz
Journal:  Am J Addict       Date:  2010 Jan-Feb

Review 5.  Methadone deaths: risk factors in pain and addicted populations.

Authors:  Vania Modesto-Lowe; Donna Brooks; Nancy Petry
Journal:  J Gen Intern Med       Date:  2010-01-20       Impact factor: 5.128

6.  Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2009 Sep-Oct

7.  Non-fatal overdose in the 12 months following treatment for substance use disorders.

Authors:  Peter C Britton; James D Wines; Kenneth R Conner
Journal:  Drug Alcohol Depend       Date:  2009-10-13       Impact factor: 4.492

8.  The nature of methadone diversion in England: a Merseyside case study.

Authors:  Paul Duffy; Helen Baldwin
Journal:  Harm Reduct J       Date:  2012-01-13

Review 9.  Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.

Authors:  Amy Wachholtz; Gerardo Gonzalez; Edward Boyer; Zafar N Naqvi; Christopher Rosenbaum; Douglas Ziedonis
Journal:  Subst Abuse Rehabil       Date:  2011-08-18

10.  Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Authors:  Kenneth Blum; David Han; John Femino; David E Smith; Scott Saunders; Thomas Simpatico; Stephen J Schoenthaler; Marlene Oscar-Berman; Mark S Gold
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.